Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
197
Views
11
CrossRef citations to date
0
Altmetric
Review

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review

Clémence Martin1 AP-HP Centre, Hôpital Cochin, Service de Pneumologie, Paris, France;2 Université de Paris, Institut Cochin, INSERM UMR 1016, Paris, France
,
Pierre-Régis Burgel1 AP-HP Centre, Hôpital Cochin, Service de Pneumologie, Paris, France;2 Université de Paris, Institut Cochin, INSERM UMR 1016, Paris, FranceORCID Iconhttps://orcid.org/0000-0003-0903-9828
ORCID Icon &
Nicolas Roche1 AP-HP Centre, Hôpital Cochin, Service de Pneumologie, Paris, France;2 Université de Paris, Institut Cochin, INSERM UMR 1016, Paris, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3162-5033
ORCID Icon
Pages 2363-2373 | Published online: 16 Aug 2021

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

James F Donohue, Tara Rheault, Margot MacDonald-Berko, Thomas Bengtsson & Kathleen Rickard. (2023) Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1611-1622.
Read now
Peng Guo, Rui Li, Tie Hua Piao, Chun Lan Wang, Xiao Lu Wu & Hong Yan Cai. (2022) Pathological Mechanism and Targeted Drugs of COPD. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1565-1575.
Read now

Articles from other publishers (9)

Katarzyna Wójcik-Pszczoła, Krzysztof Pociecha, Grażyna Chłoń-Rzepa, Monika Zadrożna, Barbara Nowak, Hanna Plutecka, Paulina Koczurkiewicz-Adamczyk, Katarzyna Przejczowska-Pomierny, Elżbieta Pękala, Reinoud Gosens & Elżbieta Wyska. (2023) Inhaled pan-phosphodiesterase inhibitors ameliorate ovalbumin-induced airway inflammation and remodeling in murine model of allergic asthma. International Immunopharmacology 119, pages 110264.
Crossref
Ivana Stolfa & Clive Page. 2023. Pulmonary Pharmacology. Pulmonary Pharmacology 55 81 .
Clémence Martin, Guillaume Chassagnon, Sven Günther, Stéfanie Habib, Jean Pastré, Pierre-Régis Burgel & Nicolas Roche. 2023. Asthma in the 21st Century. Asthma in the 21st Century 195 216 .
Katarzyna Wójcik-Pszczoła, Małgorzata Szafarz, Krzysztof Pociecha, Karolina Słoczyńska, Kamil Piska, Paulina Koczurkiewicz-Adamczyk, Natalia Kocot, Grażyna Chłoń-Rzepa, Elżbieta Pękala & Elżbieta Wyska. (2022) In silico and in vitro ADME-Tox analysis and in vivo pharmacokinetic study of representative pan-PDE inhibitors from the group of 7,8-disubstituted derivatives of 1,3-dimethyl-7H-purine-2,6-dione. Toxicology and Applied Pharmacology 457, pages 116318.
Crossref
John W. Hanrahan, Asmahan Abu-Arish, Francis H. Wong, Mark J. Turner, Graeme W. Carlile, David Y. Thomas & André M. Cantin. (2022) Chronic obstructive pulmonary disease and the modulation of CFTR by acute exposure to cigarette smoke. American Journal of Physiology-Cell Physiology 323:5, pages C1374-C1392.
Crossref
J. Ancel, M. Guecamburu, V. Marques Da Silva, P. Schilfarth, L. Boyer, C. Pilette, C. Martin, P. Devillier, P. Berger, M. Zysman, O. Le Rouzic, J. Gonzalez-Bermejo, B. Degano, P.-R. Burgel, E. Ahmed, N. Roche & G. Deslee. (2022) Principaux messages de la première Biennale BPCO 2021 de la SPLF. Mieux comprendre pour innover. Revue des Maladies Respiratoires 39:5, pages 427-441.
Crossref
Óscar López & José M. Padrón. (2022) Iridium- and Palladium-Based Catalysts in the Pharmaceutical Industry. Catalysts 12:2, pages 164.
Crossref
Erik Maronde. (2021) Cyclic Nucleotide (cNMP) Analogues: Past, Present and Future. International Journal of Molecular Sciences 22:23, pages 12879.
Crossref
Laura Carrasco-Hernández, Esther Quintana-Gallego, Carmen Calero, Rocío Reinoso-Arija, Borja Ruiz-Duque & José Luis López-Campos. (2021) Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines 9:10, pages 1437.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.